Navigation Links
Bayer HealthCare Pharmaceuticals, Inc. Announces Results of a Phase 3 Clinical Trial of Gadobutrol
Date:5/21/2010

BOSTON, May 21 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals, Inc. today announced presentation of data in a poster titled "Results from a multicenter, open-label Phase 3 study to determine the safety and efficacy of gadobutrol, a macrocyclic 1.0 molar GBCA in patients referred for contrast-enhanced MRI of the central nervous system (CNS)" at the 48th Annual Meeting of the American Society of Neuroradiology (ASNR) in Boston, MA.  The results of this study of this investigational drug met all of its pre-specified primary efficacy objectives.  Gadobutrol is investigational in the United States and is not approved by the U.S. Food and Drug Administration.

This phase 3 study had four primary efficacy objectives.  In results comparing unenhanced CNS MRI versus the combined unenhanced and gadobutrol-enhanced CNS MRI, statistically significant superiority (P<0.0001) of gadobutrol images compared to unenhanced images was shown for all three individual blinded readers as well as the average blinded reader for three of the primary efficacy variables (internal morphology, degree of contrast enhancement and border delineation).  Non-inferiority was the objective for the number of lesions detected in this study and was demonstrated for two of three blinded readers, as well as the average of the blinded readers.(1)

In the study, 14 subjects (4.1%) reported at least one adverse event which the investigators considered related to gadobutrol.  No deaths were reported during the study period, and none of the subjects discontinued from the study due to an AE.  One subject experienced a serious adverse event (SAE), which was not considered by the investigator to be related to the study drug.

"This was a large mu
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
4. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
5. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
6. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
7. FDA Approves Bayer HealthCares Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
8. Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
9. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
10. Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
11. Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... N.J. , Sept. 19, 2014 Merck (NYSE: ... States and Canada , is teaming ... Desafiando La Diabetes: Logra Tus Metas , an educational program encouraging ... blood sugar -- a key treatment goal to help reduce the ... States are at a higher risk for developing type ...
(Date:9/19/2014)... , Sept. 19, 2014 Larry J. ... CVS ), will speak before the National Press Club ... discuss the company,s recent move to stop selling tobacco products ... the future of health. "Dramatic changes in our ... care providers and government," Merlo has said. "CVS Health has ...
(Date:9/19/2014)... 19, 2014  BioSpecifics Technologies Corp. (NASDAQ: BSTC ... marketed as XIAFLEX ® in the U.S. and XIAPEX ... Tom Wegman , will present a corporate overview at ... Industry Conference. The presentation will take place ... the Millennium Broadway Hotel in New York, NY ...
Breaking Medicine Technology:Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 2Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 3Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 4Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 5CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 2CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 3BioSpecifics Technologies Corp. to Present at the 21st Annual BioCentury NewsMakers in the Biotech Industry Conference 2
... 2011 The U.S. Food and Drug Administration today ... (locally advanced or metastatic), non-small cell lung cancers (NSCLC) ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Xalkori ... will help determine if a patient has the abnormal ...
... Inc., a pioneer in the area of digital PCR, is ... to evaluate the capabilities of digital PCR and see the ... will start on Monday, September 12 in Boston and finish ... The QuantaLife ddPCR System claims to be the world,s most ...
Cached Medicine Technology:FDA Approves Xalkori with Companion Diagnostic for a Type of Late-stage Lung Cancer 2FDA Approves Xalkori with Companion Diagnostic for a Type of Late-stage Lung Cancer 3FDA Approves Xalkori with Companion Diagnostic for a Type of Late-stage Lung Cancer 4QuantaLife™ Kicks Off Droplet Digital™ PCR Road Show 2
(Date:9/20/2014)... "As a nurse, patients always ask me how much ... Tamaqua, Pa. "The reason that they cannot tell is because ... My invention enables them to check oxygen levels on their ... it easier to monitor the contents of an oxygen tank. ... is low. It allows changeovers to be performed under optimal ...
(Date:9/20/2014)... September 20, 2014 Plumbing construction ... out of 5, indicating a moderately favorable purchasing environment ... score reflects current and future pricing trends that will ... prices. Other factors that negatively affect buyer power are ... construction and the moderate switching costs. Buyers benefit, however, ...
(Date:9/20/2014)... (PRWEB) September 20, 2014 QueenBeeTickets.com is ... young star’s tour performances. She will visit many cities ... February until the 16th of April. , Click ... Honeymoon Tour tickets at QueenBeeTickets.com. , The star’s fans ... to see their favorite young singer in a live ...
(Date:9/20/2014)... California (PRWEB) September 20, 2014 Final ... have announced the release of the Information theme for FCPX ... would use to describe the Information theme,” says Christina Austin, ... easy to look so professional.” , Information features easy to ... the parameters of the environment. Change the background color, color ...
(Date:9/20/2014)... 2014 The first federal bellwether trial ... its third week in the U.S. District Court, Northern ... documents indicate that the week opened in the ... a DePuy Orthopaedics vice president, who discussed the clinical ... Pinnacle hip replacement. According to Reuters, the executive stated ...
Breaking Medicine News(10 mins):Health News:Plumbing Construction Services Procurement Category Market Research Report from IBISWorld Has Been Updated 2Health News:Plumbing Construction Services Procurement Category Market Research Report from IBISWorld Has Been Updated 3Health News:Plumbing Construction Services Procurement Category Market Research Report from IBISWorld Has Been Updated 4Health News:Discount Ariana Grande Tickets: QueenBeeTickets.com Delights Fans with Discount Concert Tickets for Ariana Grande’s 2015 Honeymoon Tour 2Health News:Today Pixel Film Studios Announced the Release of the Information Theme for Final Cut Pro X 2Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 2Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 3Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 4
... Home Products Creates Eco Site Awards to Honor Websites that Actively ... ... Feb. 20 Safe Home Products, a leading,retailer of safety, health ... program -- Eco Site Awards.,The Eco Site Awards strive to recognize ...
... New Measures Add Understanding Not Confusion, FOLSOM, Calif., ... Balint, CEO of California Walnut Commission: Given the state ... of healthy,food choices is clear. We welcome new independent ... and on packaging. While some fear,that this will be ...
... Feb. 20 LifeMasters Supported SelfCare,Inc., a ... that it,has received an extension from the ... its disease management demonstration project in Florida. ... of a disease management,program in a typically ...
... 2008 The American Cancer Societys annual cancer statistics report ... have decreased by 18.4 percent among men and by 10.5 ... the early 1990s, which translates to the avoidance of more ... United States. Society epidemiologists predict that in the U.S. in ...
... YORK, Feb. 19 On November 5, 2007, under ... worldwide sales of its drug Trasylol after a Canadian ... higher risk of death than other drugs.,The Food and ... used to prevent excessive bleeding during heart bypass surgery,pending ...
... Technologies, Inc., a,leading company in electronic medical record ... BayCare Health System of,Clearwater, FL, announced today that ... its RyTRAK HIE system to exchange clinical data,with ... care providers to exchange clinical data,seamlessly between different ...
Cached Medicine News:Health News:Eco Site Awards Launched to Honor Organizations' Devotion to Ecology, Health, Safety, and the Environment 2Health News:Walnuts Rank High on New Nutrition Scales 2Health News:Walnuts Rank High on New Nutrition Scales 3Health News:The Centers for Medicare & Medicaid Services Extends LifeMasters Demonstration Project in Florida 2Health News:The Centers for Medicare & Medicaid Services Extends LifeMasters Demonstration Project in Florida 3Health News:Report says half a million cancer deaths have been averted since death rate drop 2Health News:Report says half a million cancer deaths have been averted since death rate drop 3Health News:Report says half a million cancer deaths have been averted since death rate drop 4Health News:Report says half a million cancer deaths have been averted since death rate drop 5Health News:Randone Trasylol Lawsuit Profiled on CBS' '60 Minutes' 2Health News:Randone Trasylol Lawsuit Profiled on CBS' '60 Minutes' 3Health News:Randone Trasylol Lawsuit Profiled on CBS' '60 Minutes' 4Health News:BayCare Health System Collaborates With Accenx to Provide Reliable Exchange of Information 2
... prints labels up to 8.5 ... It is ideal for wide ... chemical drum labels, primary metal ... banner-sized labels and pallet and ...
... Korchek Technologies CareChek Tx, which ... a software device for blood ... match the patient to the ... bedside before administering a transfusion.The ...
... system ensures your patients are receiving the ... SafeTx uses the AutoPPI™ barcoded wristband to ... to transfusion. SafeTx checks that the correct ... for bedside paperwork and associated transcription errors. ...
... verification and laboratory specimen labeling system uses bar ... or nurse, the identity of the patient and ... made, a bar coded sample ID label is ... simplifies and eliminates the interface problems inherent with ...
Medicine Products: